Pregabalin for peripheral neuropathic pain: Results of a multicenter, non-comparative, open-label study in Indian patients

International Journal of Clinical Practice

Volumn 60, Issue 9, 2006, Pages 1060-1067

  Rais, Nadeem M ^a   Srinivasa, R ^b   Srinivasan, Avathvadi V ^c   Roy, Ajit K ^d   Ravat, Sangeeta H ^e   Ramachandran, Ambady ^f   Deshpande, Alaka ^g   Barman, Hemanga ^f   Oak, Pradyumna J ^e   Desai, Chetan A ^h   Sule, Neal S ^h  

^a Chowpatty Medical Center   (India)

^b M S RAMAIAH MEDICAL COLLEGE   (India)

^c R S R Trinity Acute Care Hospital   (India)

^d ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^e KEM HOSPITAL   (India)

^f Diabetes Research Center   (India)

^g SIR J J GROUP OF HOSPITALS   (India)

^h PFIZER INC   (United States)

Author keywords

Diabetic painful neuropathy; Neuropathic pain; Postherpetic neuralgia; Pregabalin

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREGABALIN;

ADULT; AGED; ARTICLE; BODY WEIGHT DISORDER; CLINICAL TRIAL; DEPRESSION; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; MCGILL PAIN QUESTIONNAIRE; MULTICENTER STUDY; MUSCLE CRAMP; NAUSEA; NEUROPATHIC PAIN; OPEN STUDY; PAIN ASSESSMENT; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SCORING SYSTEM; SLEEP DISORDER; SOMNOLENCE; STATISTICAL ANALYSIS; VISUAL ANALOG SCALE; WALKING DIFFICULTY;

ADOLESCENT; ADULT; AGED; ANALGESICS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33747162435     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01069.x     Document Type: Article

References (25)

1. Hempenstall K, Rice ASC. Current treatment options in neuropathic pain. Curr Opin Investig Drugs 2002; 3: 441-8.
2. Dworkin DH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennet GJ, et al. Advances in neuropathic pain: Diagnosis, mechanisms and treatment recommendations. Arch Neurol 2003; 60: 1524-34.
3. Tremont-Lukats IW, Megaff C, Backonja MM. Anticonvulsants for neuropathic pain syndromes: Mechanisms of action and place in therapy. Drugs 2000; 60: 1029-52.
4. Backonja M. Neuromodulating drugs for the symptomatic treatment of neuropathic pain. Curr Pain Headache Rep 2004; 8: 212-6.
5. Frampton JE, Scott LJ. Pregabalin in the treatment of painful diabetic peripheral neuropathy. Drugs 2004; 64: 2813-20.
6. Dworkin RH, Corbin AE, Young JP Jr, Sharma U, LaMoreaux L, Bockbrader H, et al. Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2003; 60: 1274-83.
7. Sabatowski R, Gálvez R, Cherry DA, Jacquot F, Vincent E, Maisonobe P, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial. Pain 2004; 109: 26-35.
8. Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized clinical trial. Neurology 2004; 63: 2104-10.
9. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial. Pain 2004; 110: 628-38.
10. Richter RW, Portenoy R, Sharma U, LaMoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial. J Pain 2005; 6: 253-60.
11. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005; 115: 254-63.
12. van Seventer R, Feister HA, Young JP Jr, Stoker M, Versavel M, Rigaudy L. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: A 13-week, randomized trial. Curr Med Res Opin 2006; 22: 375-84.
13. Melzack R. The Short-Form McGill Pain Questionnaire. Pain 1987; 30: 191-7.
14. Freynhagen R, Busche P, Konrad C, Balkenohl M. Effectiveness and time to onset of pregabalin in patients with neuropathic pain. Schmerz 2006; October 5 (Epub ahead of print).
15. Cleeland CS. Pain assessment in cancer. In: Osoba D, ed. Effect of Cancer on Quality of Life. Boca Raton, FL: CRC Press Inc., pp. 293-305.
16. Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 2004; 5: 133-7.
17. The EuroQoL Group. EuroQoL - a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
18. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: Validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997; 36: 551-9.
19. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94: 149-58.
20. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, MD: US Department of Health, Education and Welfare, 1976.
21. Sharma U, Young J, LaMoreaux L. Efficacy, safety, and tolerability of pregabalin treatment for neuropathic pain: Findings from 11 clinical trials. J Pain 2005; 6: S29 [Abstract].
22. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
23. Dworkin R, Sharma U, Stacey B, Chambers R, Siffert J. Long-term treatment of neuropathic pain and fibromyalgia syndrome with pregabalin in treatment-refractory patients. J Pain 2005; 6: S30 [Abstract].
24. Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, et al. Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52: 1264-73.
25. Siddal P, Cousins M, Otte A, Phillips K, Griesing T. Pregabalin safely and efficaciously treats chronic central neuropathic pain after spinal cord injury. J Pain 2005; 6: S25 [Abstract].